SGLT2 Inhibitors in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A Translational Synthesis From Molecular Pathways to Clinical Potential
International Journal of Rheumatic Diseases · 2026-07 · 29 (7)
DOI: 10.1111/1756-185x.70747 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 26.06.2026. Verfasst von Mislav Radić und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Allergology and Clinical Immunology, Department of Internal Medicine, Center of Excellence for Systemic Sclerosis in Croati…. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Rheumatology, Allergology and Clinical Immunology, Department of Internal Medicine, Center of Excellence for Systemic Sclerosis in Croatia, University Hospital of Split, Split, Croatia.
- Department of Internal Medicine, School of Medicine, University of Split, Split, Croatia.
- Department of Cardiovascular Diseases, University Hospital of Split, Split, Croatia.
- Division of Nephrology and Dialysis, Department of Internal Medicine, University Hospital of Split, Split, Croatia.
ORCID-Profile: Tina Đogaš
Zitieren
APA
Radić, M., Bečić, T., Prižmić, P. Š., Đogaš, T., & Radić, J. (2026). SGLT2 Inhibitors in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A Translational Synthesis From Molecular Pathways to Clinical Potential. International Journal of Rheumatic Diseases, 29(7). https://doi.org/10.1111/1756-185x.70747
Vancouver
Radić M, Bečić T, Prižmić PŠ, Đogaš T, Radić J. SGLT2 Inhibitors in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A Translational Synthesis From Molecular Pathways to Clinical Potential. International Journal of Rheumatic Diseases. 2026;29(7). doi:10.1111/1756-185x.70747
BibTeX
@article{Radi2026,
author = {Radić, Mislav and Bečić, Tina and Prižmić, Petra Šimac and Đogaš, Tina and Radić, Josipa},
title = {SGLT2 Inhibitors in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension: A Translational Synthesis From Molecular Pathways to Clinical Potential},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
volume = {29},
number = {7},
doi = {10.1111/1756-185x.70747}
}
EUVIMED